SCHEMBL2172990

SCHEMBL2172990

CC(NC(=O)CN1Cc2ccccc2C1)C(=O)Nc1ccc(Oc2ccc(F)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
LMNA P02545 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
GAA P10253 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
FNTA P49354 1/20 0.44
FNTB P49356 1/20 0.44
KMT2A Q03164 5/20 0.44
MEN1 O00255 4/20 0.44
GLA P06280 1/20 0.44
ATM Q13315 1/20 0.44
HPGD P15428 2/20 0.44
S1PR1 P21453 1/20 0.43
MAPT P10636 2/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2171615 0.83 ALDH1A1 (0.51) ALDH1A1LMNASMN1; SMN2GAAKMT2A
SCHEMBL2171842 0.83 ALDH1A1 (0.64) ALDH1A1KMT2AMEN1ATMHPGD
SCHEMBL2169800 0.83 ALDH1A1 (0.51) ALDH1A1LMNASMN1; SMN2GAAKMT2A
SCHEMBL2170390 0.82 SMN1; SMN2 (0.56) ALDH1A1LMNASMN1; SMN2GAAKMT2A
SCHEMBL2170428 0.82 ALDH1A1 (0.47) ALDH1A1LMNASMN1; SMN2GAAKMT2A
SCHEMBL1372461 0.81 S1PR1 (0.63) ALDH1A1LMNASMN1; SMN2GAAS1PR1
SCHEMBL1372463 0.81 S1PR1 (0.63) ALDH1A1LMNASMN1; SMN2GAAS1PR1
SCHEMBL2170253 0.80 ALDH1A1 (0.67) ALDH1A1LMNASMN1; SMN2GAAKMT2A
SCHEMBL2171620 0.80 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2GAACYP3A4CYP2D6
SCHEMBL2185321 0.79 IDO1 (0.47) ALDH1A1LMNASMN1; SMN2GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346821-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS Exelixis, Inc. (US) 2011-07-27 EP disclosed